Patient demand for non-surgical body contouring continues to grow as more people ask about options for localized fat that does not respond easily to diet and exercise. Injectable fat-reduction products are one category within this broader market, but they require careful patient selection, product-specific training, and clear regulatory awareness.

Aqualyx® is an injectable body-contouring product developed by Marllor Biomedical and used in some international markets for selected localized fat concerns. It is generally discussed in relation to intralipotherapy and injectable lipolysis treatment planning. However, product availability, permitted use, practitioner eligibility, and regulatory status vary by country.

This guide reviews Aqualyx® from a clinic-facing perspective, including composition, mechanism of action, possible treatment areas, patient selection, contraindications, expected recovery, safety considerations, regulatory cautions, and authentic sourcing for qualified clinics and licensed medical practitioners.

Explore professional body-contouring and aesthetic supplies available from Health Supplies Plus.

This content is intended for trained medical professionals only. It does not replace product-specific training, hands-on instruction, the manufacturer’s Instructions for Use, local regulations, clinical protocols, legal guidance, or medical judgment.

Understanding Aqualyx®

Aqualyx® is an injectable solution used in some professional body-contouring protocols for selected localized fat deposits. It is commonly associated with intralipotherapy, a technique category focused on distributing adipocytolytic agents within subcutaneous fat.

The product is generally discussed as a deoxycholate-based or cholanic-acid-derived solution designed to affect adipose tissue. Product composition, handling, and administration should always be verified through the current manufacturer documentation and local product guidance.

Practitioners should avoid presenting Aqualyx® as a simple cosmetic treatment. It is an injectable product used in a medically relevant treatment area and should only be offered by appropriately trained professionals in jurisdictions where use is permitted.

How Aqualyx® Is Intended to Work

Aqualyx® is generally discussed in relation to adipocytolysis, a process in which the injected solution disrupts fat-cell membranes in the targeted subcutaneous fat layer. The body then clears the cellular debris and lipid material over time through normal inflammatory and metabolic processes.

Because the treatment relies on a tissue response, post-treatment swelling, firmness, tenderness, and inflammation may occur. Patients should understand that visible contour changes are gradual rather than immediate.

Clinics should use cautious language around permanence. When adipocytes are successfully disrupted and cleared, the treated fat cells are not expected to function in the same way. However, overall results depend on patient selection, weight stability, treatment area, technique, number of sessions, and lifestyle factors. Remaining fat cells can still enlarge with weight gain.

Regulatory Considerations

Regulatory status should be reviewed before any clinic purchases, markets, or administers Aqualyx®.

In the United States, the FDA has warned consumers about fat-dissolving injections that are not FDA-approved and specifically lists Aqualyx® among products marketed and sold without FDA approval. The only FDA-approved fat-dissolving injectable drug in the United States is Kybella, and it is approved only for reducing moderate to severe fullness under the chin in adults.

Outside the United States, Aqualyx® may be available through professional supply channels, but clinics should confirm:

• Local regulatory status
• Practitioner eligibility
• Training requirements
• Permitted treatment areas
• Product labeling and Instructions for Use
• Insurance and liability considerations

Clinics should avoid assuming that a product permitted in one country can be used, advertised, or imported legally in another.

Common Treatment-Planning Areas

Aqualyx® is generally discussed for small, localized, pinchable pockets of subcutaneous fat. It should not be used for generalized weight loss, obesity treatment, or large-volume body reshaping.

Potential treatment-planning areas may include:

• Submental fat or “double chin” concerns where legally permitted
• Small abdominal fat pockets
• Flanks
• Hips
• Inner or outer thighs
• Selected knee-area fat deposits
• Upper arms in carefully selected patients
• Back or bra-line fat pockets
• Selected male chest fat concerns after careful diagnosis

Area selection should consider fat depth, pinchability, skin elasticity, contour goals, adjacent anatomy, medical history, and whether another treatment category would be more appropriate.

Off-Label and Higher-Responsibility Uses

Some practitioners may discuss Aqualyx® for additional localized fat concerns or special cases. These uses may be off-label or may not be supported by strong evidence in every jurisdiction.

Off-label treatment planning requires:

• Advanced anatomical knowledge
• Clear informed consent
• Documentation of rationale and alternatives
• Realistic patient education
• Product-specific training
• Awareness of increased clinical and legal responsibility

Benign fatty tumors, complex contour concerns, or male chest fullness should not be treated casually. These presentations may require diagnosis, medical evaluation, imaging, or referral before any aesthetic treatment is considered.

Patient Selection for Aqualyx®

Successful outcomes depend heavily on patient selection. Aqualyx® may be more appropriate for patients with localized subcutaneous fat rather than generalized weight concerns.

Potential candidates may include patients who have:

• Clearly defined localized fat deposits
• Stable weight
• Good or moderate skin elasticity
• Realistic expectations about gradual improvement
• Understanding that multiple sessions may be recommended
• Willingness to follow post-treatment instructions

Patients with significant skin laxity may not be ideal candidates because reducing fat volume can make laxity more noticeable. Patients seeking major reshaping or weight loss may be better suited to medical weight management, device-based treatment, liposuction, or surgical consultation.

Contraindications and Precautions

Before treatment, practitioners should complete a medical history review and confirm whether the patient is suitable under current product guidance and local clinical protocols.

Treatment may be inappropriate or require delay in patients with:

• Pregnancy or breastfeeding considerations
• Known hypersensitivity to product components
• Active infection, inflammation, or skin disease near the treatment area
• Significant liver or kidney disease
• Relevant autoimmune or connective-tissue conditions
• Bleeding disorders or anticoagulation concerns
• History of severe allergic reaction or anaphylaxis
• Unrealistic expectations
• Significant skin laxity in the treatment area
• Very thin subcutaneous fat layer
• Complex prior surgery, scarring, or contour abnormality in the area

Medication and supplement review should be part of the consultation. Patients should not stop prescribed medications unless this is coordinated with the appropriate healthcare provider.

Professional Treatment Planning

Aqualyx® treatment should only be performed by qualified professionals with product-specific training. Clinics should avoid using simplified online protocols as a substitute for formal instruction.

A responsible treatment-planning workflow may include:

1. Consultation and diagnosis: Confirm whether the concern is localized fat, skin laxity, cellulite, muscle tone, or another issue.
2. Medical screening: Review health history, allergies, medications, contraindications, and treatment suitability.
3. Photography and documentation: Record baseline appearance and treatment areas using consistent documentation methods.
4. Informed consent: Explain expected swelling, recovery, timeline, risks, alternatives, and limitations.
5. Product verification: Confirm authenticity, lot number, expiration date, storage, and regulatory status.
6. Aftercare planning: Provide written post-treatment guidance and clear instructions for concerning symptoms.

Detailed injection technique, spacing, volume, and device selection should follow official training, the current Instructions for Use, and local clinical protocols. They should not be improvised from general web content.

Expected Results and Recovery

Results from injectable fat-reduction treatments are gradual. Patients may notice changes over several weeks as swelling resolves and the treated tissue response develops. More than one session may be recommended depending on the treatment area, fat volume, patient goals, and practitioner assessment.

Post-treatment effects may include:

• Swelling
• Bruising
• Tenderness
• Redness or warmth
• Temporary firmness
• Small nodules or unevenness during the settling period
• Temporary numbness or sensitivity changes

Swelling can be noticeable after injectable fat-reduction treatments. Patients should be counseled before treatment so the recovery experience does not come as a surprise.

Aftercare Considerations

Aftercare should be tailored to the treatment area, product guidance, and clinic protocol. Written instructions help patients understand what is expected and when to contact the clinic.

Depending on the treatment plan, patients may be advised to:

• Use compression garments where appropriate and recommended
• Avoid strenuous exercise for a short period
• Avoid excessive heat, saunas, steam rooms, or hot baths for a short period
• Avoid alcohol for a short period if recommended by the clinic
• Stay well hydrated
• Follow any massage or movement instructions provided by the treating practitioner
• Contact the clinic promptly with concerning symptoms

Patients should not be given universal massage or medication instructions without practitioner-specific guidance. Aftercare should reflect the product, area treated, patient history, and clinic protocol.

Potential Side Effects and Complications

Injectable fat-reduction treatments can cause expected inflammatory effects and, less commonly, more serious complications. Informed consent should clearly distinguish normal recovery from warning signs.

Common or Expected Effects

• Swelling
• Bruising
• Tenderness or soreness
• Redness
• Warmth
• Firmness or temporary nodularity

Less Common or More Serious Concerns

• Persistent nodules
• Contour irregularities
• Skin injury or necrosis, especially if product is placed too superficially
• Infection
• Hyperpigmentation
• Scarring
• Allergic or systemic reaction
• Unsatisfactory aesthetic outcome

Patients should contact the clinic urgently if they experience severe or worsening pain, spreading redness, fever, drainage, skin breakdown, unusual discoloration, severe swelling, breathing symptoms, or any concerning systemic reaction.

Aqualyx® vs. Weight Loss, Liposuction, and Devices

Aqualyx® should be positioned as a localized body-contouring option, not a substitute for weight loss. It does not treat obesity, improve overall metabolic health, or replace lifestyle support.

It is also not equivalent to liposuction. Surgical fat removal can produce more dramatic volume reduction in appropriate patients, while injectable fat-reduction treatments are generally discussed for smaller, more localized concerns.

For some patients, other options may be more appropriate, including:

• Medical weight management
• Nutrition and lifestyle support
• Cryolipolysis
• Radiofrequency or ultrasound-based body contouring
• Skin-tightening devices
• Liposuction
• Surgical body contouring

The best recommendation depends on whether the patient’s concern is fat volume, skin laxity, cellulite, muscle tone, or a combination of factors.

Sourcing Authentic Aqualyx®

Authentic sourcing is essential for patient safety and predictable treatment planning. Counterfeit, expired, improperly stored, or unauthorized injectable products can create serious risks.

Clinics should verify:

• Supplier reputation and eligibility requirements
• Product authenticity checks, including manufacturer verification tools where available
• Packaging integrity
• Lot number and expiration date
• Storage and handling requirements
• Product labeling and documentation
• Regulatory status in the clinic’s jurisdiction

Explore professional aesthetic supplies at Health Supplies Plus.

Frequently Asked Questions About Aqualyx®

What is Aqualyx®?

Aqualyx® is an injectable body-contouring product used in some international markets for selected localized fat concerns. Regulatory status and permitted use vary by jurisdiction.

Is Aqualyx® FDA-approved in the United States?

No. The FDA has listed Aqualyx® among fat-dissolving injections marketed without FDA approval in the United States. Kybella is the only FDA-approved fat-dissolving injectable drug in the U.S., and only for submental fat in adults.

Is Aqualyx® a weight-loss treatment?

No. Aqualyx® is generally discussed for selected localized fat deposits. It is not intended for generalized weight loss or obesity treatment.

How does Aqualyx® work?

Aqualyx® is generally discussed in relation to adipocytolysis, where the injected product disrupts fat-cell membranes in the targeted subcutaneous fat layer. The body clears cellular debris and lipid material gradually over time.

What areas may be treated with Aqualyx®?

Potential treatment-planning areas may include selected localized fat deposits in areas such as the submental region, abdomen, flanks, hips, thighs, upper arms, knees, or back, depending on local regulations and patient suitability.

Who may be a good candidate for Aqualyx®?

A suitable candidate may have stable weight, clear localized subcutaneous fat, adequate skin elasticity, realistic expectations, and no contraindications based on medical history or product guidance.

Who should avoid Aqualyx®?

Patients with pregnancy or breastfeeding considerations, active infection, significant liver or kidney disease, relevant autoimmune conditions, bleeding disorders, product hypersensitivity, unrealistic expectations, or significant skin laxity may not be suitable.

What side effects can occur after Aqualyx®?

Swelling, bruising, tenderness, redness, warmth, firmness, and temporary nodularity may occur. Less common complications can include infection, contour irregularities, skin injury, scarring, or systemic reactions.

How long do results take?

Visible improvement is gradual and varies by patient, treatment area, number of sessions, degree of fat, and individual response. Patients should receive realistic timelines during consultation.

Who should administer Aqualyx®?

Aqualyx® should only be administered by qualified, trained medical professionals in jurisdictions where use is permitted and in accordance with product instructions, local laws, and appropriate safety protocols.

Conclusion

Aqualyx® may have a role in selected international body-contouring treatment plans for localized subcutaneous fat, but it requires careful regulatory review, patient selection, product-specific training, and realistic expectation management.

Clinics should position Aqualyx® as a localized contouring treatment rather than a weight-loss solution or liposuction replacement. They should also avoid broad claims of permanence, predictability, or universal suitability.

For qualified clinics and licensed medical practitioners, reliable sourcing and proper training are essential when offering injectable body-contouring treatments.

Explore professional body-contouring and aesthetic supplies at Health Supplies Plus.

This content is intended for professional informational purposes only and does not replace medical advice, diagnosis, treatment, product-specific training, hands-on instruction, emergency protocols, manufacturer instructions, legal guidance, regulatory guidance, or applicable clinical protocols. Injectable fat-reduction and body-contouring treatments should only be performed by qualified professionals in accordance with local laws, product labeling, scope-of-practice rules, and appropriate standards of care.

Doris

About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.

Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.